Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1376124 | Bioorganic & Medicinal Chemistry Letters | 2008 | 5 Pages |
The design, synthesis and structure–activity relationship studies of a novel series of CRF-1 receptor antagonists, the 2-arylpyrimidines, are described. The effects of substitution on the aromatic ring and the pyrimidine core on CRF-1 receptor binding were investigated. A number of compounds with Ki values below 10 nM and lipophilicity in a minimally acceptable range for a CNS drug (cLog P < 5) were discovered.
Graphical abstractThe design, synthesis, and structure–activity relationship studies of a novel series of CRF-1 receptor antagonists, the 2-arylpyrimidines, are described. The effects of substitution on the aromatic ring and the pyrimidine core on CRF-1 receptor binding were investigated. A number of compounds with Ki values below 10 nM and lipophilicity in a minimally acceptable range for a CNS drug (cLog P < 5) were discovered.Figure optionsDownload full-size imageDownload as PowerPoint slide